Cellectis S.A.
CLLS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $286 | $153 | $124 | $180 |
| - Cash | $52 | $60 | $128 | $143 |
| + Debt | $38 | $95 | $92 | $91 |
| Enterprise Value | $271 | $188 | $88 | $128 |
| Revenue | $35 | $17 | $11 | $13 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Gross Profit | $33 | $14 | $9 | $10 |
| % Margin | 93.3% | 85.5% | 81.1% | 80.2% |
| EBITDA | $8 | -$17 | -$11 | $14 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |
| Net Income | $1 | -$24 | -$18 | $6 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.059 |
| % Growth | 102.5% | -33.3% | -404.1% | – |
| Operating Cash Flow | -$2 | -$10 | -$17 | -$0 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$2 |
| Free Cash Flow | -$3 | -$11 | -$18 | -$2 |